May 24, 2017
Tardive Dyskinesia (TD) is a neurological disorder caused by long term use of anti-psychotic medications. It occurs in 10-20 percent of individuals treated with anti-psychotic medications; the elderly are more susceptible to persistent and irreversible TD than younger people.
Assessing and monitoring for TD is essential in treatment. The DISCUS (Dyskinesia Identification System Condensed User Scale) is a rating scale used to measure TD; the MOSES (Monitoring of Side Effects Scale) is a general side effect assessment scale for psychotropic medications. Effective monitoring leads to more effective treatment.
Learn more: Tardive Dyskinesia
Learn how by signing up for DISCUS/MOSES: Monitoring Tardive Dyskinesia